Factors Associated With Adherence To Long-Acting Inhaled Therapies Among Patients With COPD

被引：0
|
作者：
Cecere, L. M.
Slatore, C. G.
Uman, J.
Evans, L.
Udris, E. M.
Bryson, C. L.
Au, D. H.
机构：
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2011年 / 183卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A2259
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Long-acting bronchodilators with or without inhaled corticosteroids and 30-day readmission in patients hospitalized for COPD
    Bishwakarma, Raju
    Zhang, Wei
    Kuo, Yong-Fang
    Sharma, Gulshan
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2017, 12 : 477 - 486
  • [42] Eligibility of real-life patients with COPD for inclusion in trials of inhaled long-acting bronchodilator therapy
    Halpin, David M. G.
    Kerkhof, Marjan
    Soriano, Joan B.
    Mikkelsen, Helga
    Price, David B.
    RESPIRATORY RESEARCH, 2016, 17
  • [43] LESS THAN 20% OF COPD PATIENTS PERSIST WITH LONG-ACTING INHALED DRUGS FOR AT LEAST THREE YEARS
    Penning-van, Beest F. J. A.
    van Herk-Sukel, M. P. P.
    Lammers, J. W. J.
    Gale, R.
    Herings, R. M. C.
    VALUE IN HEALTH, 2009, 12 (07) : A299 - A299
  • [44] Eligibility of real-life patients with COPD for inclusion in trials of inhaled long-acting bronchodilator therapy
    David M. G. Halpin
    Marjan Kerkhof
    Joan B. Soriano
    Helga Mikkelsen
    David B. Price
    Respiratory Research, 17
  • [45] Long-Acting Bronchodilators and Arterial Stiffness in Patients With COPD
    Pepin, Jean-Louis
    Cockcroft, John R.
    Midwinter, Dawn
    Sharma, Sanjay
    Rubin, David B.
    Andreas, Stefan
    CHEST, 2014, 146 (06) : 1521 - 1530
  • [46] Long-Acting Bronchodilators And Arterial Stiffness In Patients With COPD
    Rubin, D. B.
    Pepin, J. -L.
    Cockcroft, J. R.
    Midwinter, D.
    Sharma, S.
    Andreas, S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [47] Adherence to inhaled therapies, health outcomes and costs in patients with asthma and COPD
    Makela, Mika J.
    Backer, Vibeke
    Hedegaard, Morten
    Larsson, Kjell
    RESPIRATORY MEDICINE, 2013, 107 (10) : 1481 - 1490
  • [48] Characterization Of COPD Patients Treated With Inhaled Triple Therapy Containing Inhaled Corticosteroids [ics], Long-Acting Beta2-Agonists [laba], And Long-Acting Muscarinic Antagonists [lama] In The Uk
    Mullerova, H.
    Maskell, J.
    Meeraus, W. H.
    Galkin, D.
    Albers, F. C.
    Gait, C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [49] Safety and Efficacy of Combined Long-Acting β-Agonists and Inhaled Corticosteroids vs Long-Acting α-Agonists Monotherapy for Stable COPD A Systematic Review
    Rodrigo, Gustavo J.
    Castro-Rodriguez, Jose A.
    Plaza, Vicente
    CHEST, 2009, 136 (04) : 1029 - 1038
  • [50] Risk of active tuberculosis among COPD patients treated with fixed combinations of long-acting beta2 agonists and inhaled corticosteroids
    Huang, Tsan-Ming
    Kuo, Kuan-Chih
    Wang, Ya-Hui
    Wang, Cheng-Yi
    Lai, Chih-Cheng
    Wang, Hao-Chien
    Chen, Likwang
    Yu, Chong-Jen
    BMC INFECTIOUS DISEASES, 2020, 20 (01)
12345